FDA Drug recall D-1256-2020
Esomeprazole Magnesium Delayed Release Capsules USP, 40 mg*, 1000-count bottles, Rx only, Mfd
- FDA Drug
- Class III
- terminated
- Published 2020-05-06
On 2020-05-06 the FDA classified a Class III recall of Esomeprazole Magnesium Delayed Release Capsules USP, 40 mg*, 1000-count bottles, Rx only, Mfd by Dr Reddy S Laboratories, citing discoloration: product contains brown pellets.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1256-2020 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2020-04-24 |
| Published | 2020-05-06 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Esomeprazole Magnesium Delayed Release Capsules USP, 40 mg*, 1000-count bottles, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 INDIA, NDC 43598-510-10
Reason
Discoloration: product contains brown pellets
Identifiers
| ndc | 43598-509-30 |
|---|---|
| ndc | 43598-509-90 |
| ndc | 43598-509-10 |
| ndc | 43598-510-30 |
| ndc | 43598-510-90 |
| ndc | 43598-510-10 |
| code_info | Lot #: C900642, Exp. 06/2020 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1256-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.